Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill shows promise for Hard-to-Treat blood cancers

NCT ID NCT05602363

First seen Nov 03, 2025 · Last updated May 01, 2026 · Updated 22 times

Summary

This study tests an experimental oral drug, AS-1763, in adults with certain blood cancers (like CLL or lymphoma) that have not responded to at least two prior treatments. The main goals are to find the safest dose and see how well the drug controls the cancer. About 120 participants will take the pill daily, and researchers will monitor side effects and tumor response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • American Oncology Partners

    RECRUITING

    Fort Wayne, Indiana, 46804, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Duke University

    RECRUITING

    Durham, North Carolina, 27705, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Mount Sinai Comprehensive Cancer Center

    RECRUITING

    Miami Beach, Florida, 33140, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Northwestern Memorial Hospital

    RECRUITING

    Chicago, Illinois, 60661, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Oncology Consultants

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Optum Medical Care PC

    RECRUITING

    Westbury, New York, 11590, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Taylor Cancer Research Center

    RECRUITING

    Maumee, Ohio, 43537, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53266, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UC Irvine Health

    RECRUITING

    Orange, California, 92868, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Maryland Medical Center - Greenebaum Comprehensive Cancer Center

    RECRUITING

    Baltimore, Maryland, 21201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Massachusetts Memorial Medical Center

    RECRUITING

    Worcester, Massachusetts, 01655, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.